Alyaa Ajabnoor

Our new paper is out @JAHA_AHA ahajournals.org/doi/full/10.11… Led by @dataevan We examined how certain types of cancer influence the balance between stroke and bleeding risk in patients with NVAF @mmamas1973 @Salwasz278 @RosaParisi09 Prof. Ashcroft @finn_corinne & Dr. Charlotte Morris

Our analysis led by @alyaa_an studying Performance of CHA2DS2-VASc and HAS-BLED in predicting stroke and bleeding in atrial fibrillation and patients with cancer .@ESC_Journals ➡️ academic.oup.com/ehjopen/articl… 💥 CHA2DS2-VASc has similar discrimination in patients with and without cancer 💥 HAS-BLED performs poorly in patients with cancer (worse in colorectal, haematological and breast cancers) 💥 need better risk prediction in patients with cancer particularly when under-prescription of anticoagulants in cancer pts ➡️acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @mirvatalasnag @AndrewJSauer @cpgale3 @vass_vassiliou @purviparwani @vass_vassiliou @drKamarajk @DrAsifQasim @iamritu @KardiologieHH @Hragy

Our new paper is out led by @dataevan & an amazing team involving @mmamas1973 Prof.Ashcroft @Salwasz278 @RosaParisi09 @finn_corinne We have examined the performance of stroke and bleeding risk assessment scores in AF patient with certain types of cancer doi.org/10.1093/ehjope…

@mmamas1973 @purviparwani @DrMarthaGulati @dataevan @RosaParisi09 @Salwasz278 Thank you Mamas for this thread. It was a great privilege to work with you and will forever be grateful for that experience 😊

@purviparwani @DrMarthaGulati 3. @alyaa_an who undertook a PhD with @dataevan and myself, has published many important papers around AF and its management in patients with cancer, aswell as @RosaParisi09 and @Salwasz278 who have supported many of our works with methodology, and have involved me in theirs

1. #InternationalWomensDay It is often highlighted how men can support women, but very little is written about the many women that have supported men's careers including my own - i will be forever grateful for all the opportunities afforded to me by the many women i work with. I wanted to highlight some of the brilliant women that i have worked with who have supported my career over the past year with my annual thread. @mirvatalasnag a powerhouse, iconic IC and a friend- who invited me to be a co-director for #TCT_Plus_MiddleEast @alaide_chief president elect of EAPCI, a friend and supporter who has supported me professionally and collaboratively @hvanspall a role model clinican scientist that has hugely contributed to my groups work and invited me to contribute to her programs, and friend @zahra_raisi who has worked within my group and produced some high impact work around CV disease in pts with cancer

New & available #OpenAccess from @alyaa_an et al | Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009–2019 acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert

Our analysis led by @alyaa_an using UK national data shows Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England is much less than in patients without cancer, esp haematological malignancies snd lung CA, even though these pts are at higher stroke risk. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @dataevan @RosaParisi09 @Salwasz278 @OncoCard_Ganken #cardiooncology @kamleshkhunti @parthaskar @onco_cardiology @KardiologieHH @hvanspall @DrMarthaGulati @iamritu @AnastasiaSMihai @KemalogluOz @CardioOncology @CardioOncCOIN @Cardioonc_bot

@Muradi_Ban @JAHA_AHA @dataevan @mmamas1973 @Salwasz278 @RosaParisi09 @finn_corinne الله يبارك فيكي مرادي آمين وياكي يا رب😊❤️

@alyaa_an @JAHA_AHA @dataevan @mmamas1973 @Salwasz278 @RosaParisi09 @finn_corinne الف الف مبروك لولا ومنها للاعلى يارررررب ❤️❤️❤️

Our new paper is out @JAHA_AHA ahajournals.org/doi/full/10.11… Led by @dataevan We examined how certain types of cancer influence the balance between stroke and bleeding risk in patients with NVAF @mmamas1973 @Salwasz278 @RosaParisi09 Prof. Ashcroft @finn_corinne & Dr. Charlotte Morris

@mmamas1973 Likewise Mamas 😊 Very grateful to have worked with you. Your guidance is highly appreciated.

Congratulations @alyaa_an been a pleasure to work with you on this

@mmamas1973 @warkaa21 @foziaahmedMD @jedicath @gina_lundberg @TomVargheseJr @UmairQa94231960 @kamleshkhunti @AlexFrogoudaki @DrRiaz919 @YRodriguezMD Great thread @mmamas1973 I feel so honoured to be included in it 😊

5. Internal Womens Day- To the PhD /MD students who are researchers first, women second that i currently supervise who have between them produced some amazing work such as Fendy Zhang, @warkaa21 @alyaa_an and ex students such as vicky Taxiarchi, @foziaahmedMD , Zeinab Hegab who have excelled in their careers- some like @foziaahmedMD will hopefully be full professors in the future

1. International Women's Day - A (longish thread) thread. I wanted to thank all the brilliant women that have supported my career in the past year. All the world class researchers with their own programs of research that have collaborated with me including @hvanspall @ReechaSofat @sunlouise1 @Dr_MPanagioti

Morning coffee lovers! Decaffeinated, ground & instant coffee ( esp 2–3 cups/day associated with ⬇️incidence of cardiovascular disease & mortality. Ground and instant but not decaffeinated coffee associated with ⬇️ risk of arrhythmia academic.oup.com/eurjpc/advance…

A new ISPE sponsored manuscript provides guidance on the use of visualizations throughout the lifecycle of a pharmacoepidemiology study - these help to support transparent and unambiguous communication from study design to results onlinelibrary.wiley.com/doi/10.1002/pd…

Delighted to see our recent study picked up by the official journal of the Royal Pharmaceutical Society @PJOnline_News pharmaceutical-journal.com/article/news/d… Full study @PLOSMedicine journals.plos.org/plosmedicine/a…

Someone asked me yesterday whether disparities in #AFib treatment exist in the UK. 👇🏾 “Compared to white ethnicity, patients from black and other ethnic minorities were ⬇️ likely to receive OAC; 0.78 (0.65; 0.94) & 0.76 (0.64; 0.91).” journals.plos.org/plosmedicine/a… #Pharmacoequity

الترميز الطبي Medical Coding يعتبر علم بحد ذاته وله أهمية كبيرة في أي نظام صحي لإخراج بيانات صحيحة ودقيقة. أتمنى أن ينال هذا المجال أهمية من كل الجهات المتعلقة بالنظام الصحي سواء الحكومي أو الخاص. @SaudiMOH #الترميز_الطبي #coding #healthcare

@RosaParisi09 @dataevan @Salwasz278 @mmamas1973 @RutterMK @narodmit Thank you Rosa and for being part of an excellent supervisory team 😊

@alyaa_an @dataevan @Salwasz278 @mmamas1973 @RutterMK @narodmit Well done Alyaa!

Just published our study involving @dataevan @Salwasz278 @RosaParisi09 @mmamas1973 Prof. Ashcroft @RutterMK @narodmit & Dr. Matthew Carr. On the incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019 dx.plos.org/10.1371/journa…

Thanks to @bmj_latest for highlighting our study. Full-paper @PLOSMedicine doi.org/10.1371/journa… #primarycare #bigdata #healthequity #cardiovascular @PrimaryCareMcr @PharmacyDUPP @OfficialUoM @KAUPharmacy twitter.com/bmj_latest/sta…

Using primary care data from @CPRD we found that... NVAF patients living in IMD 5 were 15% less likely to receive OAC, compared to patients living in IMD 1. and compared to White patients, Black and other ethnic minorities patients were 22%, and 24% less likely to receive OAC.

Our analysis shows.. That the incidence rates of NVAF rose by almost a quarter in England between 2009 and 2019, and there are ethnic and socioeconomic inequalities of care for atrial fibrillation patients in England.